Nabila Abdelmeguid

Prof. Dr. Nabila Abdelmeguid

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2010 in Journal of Diabetes
Verified
Journal Article
Closed access
PDF file
NANabila Abdelmeguid
Nabila Abdelmeguid
RFRajaa Fakhoury
Rajaa Fakhoury
SKSalwa M. Kamal
Salwa M. Kamal
RWRana J. AL Wafai
Rana J. AL Wafai

12 April 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
RHReham Hamida
Reham Hamida
MAMohamed Ali
Mohamed Ali
NANabila Abdelmeguid
Nabila Abdelmeguid
MAMayasar I. Al-Zaban
Mayasar I. Al-Zaban
LINA BAZLINA BAZ
LINA BAZ
MBMashael Bin-Meferij
Mashael Bin-Meferij
Green synthesis of nanoparticles (NPs) is a safe, eco-friendly, and relatively inexpensive alternative to conventional routes of NPs production. These methods require natural resources such as cyanobacteria, algae, plants, fungi, lichens, and naturally extracted biomolecules such as pigments, vitamins, polysaccharides, proteins, and enzymes to reduce bulk materials (the target metal salts) into a nanoscale product. Synthesis of nanomaterials (NMs) using lichen extracts is a promising eco-friendly, simple, low-cost biological synthesis process. Lichens are groups of organisms including multiple types of fungi and algae that live in symbiosis. Until now, the fabrication of NPs using lichens has remained largely unexplored, although the role of lichens as natural factories for synthesizing NPs has been reported. Lichens have a potential reducible activity to fabricate different types of NMs, including metal and metal oxide NPs and bimetallic alloys and nanocomposites. These NPs exhibit promising catalytic and antidiabetic, antioxidant, and antimicrobial activities. To the best of our knowledge, this review provides, for the first time, an overview of the main published studies concerning the use of lichen for nanofabrication and the applications of these NMs in different sectors. Moreover, the possible mechanisms of biosynthesis are discussed, together with the various optimization factors influencing the biological synthesis and toxicity of NPs.

1 March 2008 in Pesticide Biochemistry and Physiology
Verified
Journal Article
Closed access
MRMohamed A. Radwan
Mohamed A. Radwan
AEA.E. Essawy
A.E. Essawy
NANabila Abdelmeguid
Nabila Abdelmeguid
SHS.S. Hamed
S.S. Hamed
AAA.E. Ahmed
A.E. Ahmed

8 August 2022 in Neurochemical Research
Verified
Journal Article
Open access
PDF file
NANabila Abdelmeguid
Nabila Abdelmeguid
THTasneem M. Hammad
Tasneem M. Hammad
AAAshraf Abdel-Moneim
Ashraf Abdel-Moneim
SSSherine Abdel Salam
Sherine Abdel Salam
Epigallocatechin 3-gallate (EGCG) is a natural polyphenolic antioxidant in green tea leaves with well-known health-promoting properties. However, the influence of EGCG on a chronic animal model of depression remains to be fully investigated, and the details of the molecular and cellular changes are still unclear. Therefore, the present study aimed to investigate the antidepressant effect of EGCG in mice subjected to chronic unpredictable mild stress (CUMS). After eight consecutive weeks of CUMS, the mice were treated with EGCG (200 mg/kg b.w.) by oral gavage for two weeks. A forced swimming test (FST) was used to assess depressive symptoms. EGCG administration significantly alleviated CUMS-induced depression-like behavior in mice. EGCG also effectively decreased serum interleukin-1β (IL-1β) and increased the mRNA expression levels of brain-derived neurotrophic factor (BDNF) in the hippocampal CA3 region of CUMS mice. Furthermore, electron microscopic examination of CA3 neurons in CUMS mice showed morphological features of apoptosis, loss or disruption of the myelin sheath, and degenerating synapses. These neuronal injuries were diminished with the administration of EGCG. The treatment effect of EGCG in CUMS-induced behavioral alterations was comparable with that of clomipramine hydrochloride (Anafranil), a tricyclic antidepressant drug. In conclusion, our study demonstrates that the antidepressive action of EGCG involves downregulation of serum IL-1β, upregulation of BDNF mRNA in the hippocampus, and reduction of CA3 neuronal lesions.

10 May 2008 in Cell Biology and Toxicology
Verified
Journal Article
Closed access
PDF file
AEAmina E. Essawy
Amina E. Essawy
NANabila Abdelmeguid
Nabila Abdelmeguid
MRMohamed A. Radwan
Mohamed A. Radwan
SHSherifa S. Hamed
Sherifa S. Hamed
AHAmira E. Hegazy
Amira E. Hegazy